Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. Eur J Cancer. 2019 10; 120:132-139.
View in:
PubMed
subject areas
Aged
Alanine
Antineoplastic Agents
Biomarkers, Tumor
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasms
Prognosis
Survival Rate
Triazines
Withholding Treatment
authors with profiles
Mark J. Ratain
Bruce E. Brockstein